6-chloro-4MDMPA,
6-chloro-9-(4-methoxy-3,5-dimethylpyridin-2-ylmethyl)-9H-purin-2-ylamine,
BIIB021,
CNF 2024,
CNF-2024,
CNF2024,
BIIB021,
848695-25-0,
6-chloro-9-((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)-9H-purin-2-amine,
CNF2024,
BIIB 021,
BIIB-021,
UNII-851B9FQ7Q0,
CHEMBL467399,
CHEBI:90687,
851B9FQ7Q0,
CNF 2024,
6-Chloro-9-[(4-Methoxy-3,5-Dimethylpyridin-2-Yl)methyl]-9h-Purin-2-Amine,
AK104952,
6-chloro-9-((4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)-9h-purin-2-amine,
6-chloro-9-(4-methoxy-3,5-dimethyl-pyridin-2-ylmethyl)-9H-purin-2-ylamine,
6-Chloro-9-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]-9h-purin-2-amine,
6-chloro-9-[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]purin-2-amine,
94M,
3qdd,
QULDDKSCVCJTPV-UHFFFAOYSA-N,
CNF-2024,
MLS006011080,
GTPL9258,
SCHEMBL1791028,
BIIB021,CNF2024,
BIIB021/CNF2024,
BDBM20800,
CTK8C3937,
AOB4502,
EX-A681,
QCR-185,
BIIB021(CNF2024),
BIIB021; CNF2024,
CNF2024, BIIB021,
BCPP000335,
HMS3654G16,
BCP02111,
KS-00001CQ1,
2-amino-6-halopurine analogue, 20,
ABP000837,
ANW-70835,
MFCD15528939,
s1175,
ZINC14974583,
(6-Chloro-9-(4-methoxy-3,5-dimethylpyridin-2-ylmethyl)-9h-purin-2-yl)amine,
9H-purin-2-amine, 6-chloro-9-((4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)-,
AKOS015969048,
BCP9000411,
CS-0168,
DB12359,
RL05218,
SB16641,
NCGC00247877-01,
4CA-0277,
AJ-65528,
BC660077,
HY-10212,
SMR004702868,
AB0008087,
AX8239160,
TC-159580,
FT-0696777,
ST24045314,
SW220186-1,
X7555,
W-5597,
J-518605,
BRD-K51967704-001-01-0,
EC-82, Conforma,
EC-145, Conforma,
D05HWN,
C14H15ClN6O,
cc-544,
EC-78,
EC-89,
CNF-3647,
EC-129,
EC-137,
EC-138,
EC-141,
EC-144,
EC-146,
EC-147,
EC-151,
ACN-025760,
Hsp90 inhibitor (cancer), Biogen Idec,
A4058,
A10143,
Synthetic Hsp90 inhibitors (cancer), Conforma,
Hsp90 inhibitors (synthetic, cancer), Conforma,
9H-Purin-2-amine, 6-chloro-9-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]-,